<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate the clinical significance of hypermethylation of the calcitonin (CT) gene in malignant <z:e sem="disease" ids="C0947743,C0018939" disease_type="Disease or Syndrome" abbrv="">hematological disorders</z:e> (MHD) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Polymerase chain reaction (PCR) in combination with digestion of DNA with Hpa II was used to examine the methylation patterns of the CT gene in 73 patients with MHD, 6 healthy people and 24 patients with nonmalignant <z:e sem="disease" ids="C0947743,C0018939" disease_type="Disease or Syndrome" abbrv="">hematological disorders</z:e> (NON-MHD) </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Hypermethylation of the CT gene occurred in 12 of 14 (85.7%) patients with <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (ALL), 9 of 15 (60%) <z:hpo ids='HP_0011009'>acute</z:hpo> nonlymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (ANLL), 8 of 10 (80%) <z:hpo ids='HP_0005506'>chronic myelogenous leukemia</z:hpo> (<z:mp ids='MP_0005481'>CML</z:mp>), 5 of 15 (33.3%) malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (ML), 2 of 5 patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), 1 of 2 malignant <z:mpath ids='MPATH_146,MPATH_652'>histiocytosis</z:mpath> (MH), 1 of 3 <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> (CLL) and 1 of 9 <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> (MM) </plain></SENT>
<SENT sid="3" pm="."><plain>However, it did not occur in <z:mpath ids='MPATH_458'>normal</z:mpath> controls and NON-MHD </plain></SENT>
<SENT sid="4" pm="."><plain>CONCLUSION: Hypermethylation of CT gene may serve as an important molecular maker for tumorous cell clone and may be useful in diagnosing MHD, monitoring <z:e sem="disease" ids="C0242596" disease_type="Neoplastic Process" abbrv="MRD">minimal residual disease</z:e> and predicting prognosis </plain></SENT>
</text></document>